NASDAQ, TSX: NVCN
VANCOUVER, March 14, 2017 /PRNewswire/ - Neovasc Inc.
("Neovasc" or the "Company") (NASDAQ, TSX: NVCN)
today announced that it will release its financial results for the
fourth quarter and fiscal year 2016 on Thursday, March 23,
2017, after markets close. The Company will subsequently hold a
conference call that same day, Thursday,
March 23, 2017, at 4:30 pm Eastern Time hosted by
Mr. Alexei Marko, Chief Executive Officer, and Mr. Chris
Clark, Chief Financial Officer. A question and answer session will
follow the corporate update.
|
Conference Call
Details
|
|
DATE:
|
Thursday, March 23,
2017
|
|
TIME:
|
4:30 pm
ET
|
|
DIAL-IN
NUMBER:
|
888 390 0546 or 416
764 8688
|
A link to the live audio webcast of the conference call will
also be available on the Presentations and Events page of the
Investors section of Neovasc's website at
www.neovasc.com. Please connect at least 15 minutes prior to the
conference call to ensure adequate time for any software download
that may be required to hear the webcast.
A recording of the call will be available for 72 hours by
calling 888 390 0541 or 416 764 8677 and using passcode
034470#.
About Neovasc Inc.
Neovasc is a specialty medical device company that develops,
manufactures and markets products for the rapidly growing
cardiovascular marketplace. Its products include the Neovasc
Reducer™, for the treatment of refractory angina which
is not currently available in the U.S. and has been available in
Europe since 2015 and the
Tiara™, for the transcatheter treatment of mitral valve
disease, which is currently under investigation in the U.S.,
Canada and Europe. The Company also sells a line of
advanced biological tissue products that are used as key components
in third-party medical products including transcatheter heart
valves. For more information, visit: www.neovasc.com.
SOURCE Neovasc Inc.